DALLOCCHIO, Franco Pasquale Filippo
 Distribuzione geografica
Continente #
NA - Nord America 12.289
AS - Asia 6.216
EU - Europa 3.787
SA - Sud America 1.064
AF - Africa 102
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 13
Totale 23.485
Nazione #
US - Stati Uniti d'America 12.085
SG - Singapore 2.356
CN - Cina 2.063
UA - Ucraina 914
BR - Brasile 900
DE - Germania 780
HK - Hong Kong 585
TR - Turchia 533
IT - Italia 437
GB - Regno Unito 423
VN - Vietnam 332
FI - Finlandia 302
RU - Federazione Russa 241
SE - Svezia 222
PL - Polonia 146
CA - Canada 92
MX - Messico 92
IN - India 85
AR - Argentina 74
FR - Francia 73
JP - Giappone 47
ZA - Sudafrica 47
ID - Indonesia 39
EE - Estonia 36
BD - Bangladesh 33
CZ - Repubblica Ceca 32
NL - Olanda 32
ES - Italia 28
BE - Belgio 26
IQ - Iraq 25
LT - Lituania 21
EC - Ecuador 17
CO - Colombia 16
CL - Cile 15
IR - Iran 15
PY - Paraguay 15
AT - Austria 14
UZ - Uzbekistan 13
EG - Egitto 11
PK - Pakistan 11
AU - Australia 10
MA - Marocco 10
BG - Bulgaria 9
EU - Europa 9
SA - Arabia Saudita 9
SD - Sudan 9
UY - Uruguay 9
MY - Malesia 8
PE - Perù 8
RO - Romania 8
VE - Venezuela 8
IE - Irlanda 6
IL - Israele 6
KR - Corea 6
TN - Tunisia 6
TW - Taiwan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AZ - Azerbaigian 5
JM - Giamaica 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
AO - Angola 4
CH - Svizzera 4
DK - Danimarca 4
DZ - Algeria 4
ET - Etiopia 4
KE - Kenya 4
KW - Kuwait 4
LB - Libano 4
PT - Portogallo 4
GE - Georgia 3
GR - Grecia 3
LV - Lettonia 3
MD - Moldavia 3
MT - Malta 3
NI - Nicaragua 3
NP - Nepal 3
NZ - Nuova Zelanda 3
OM - Oman 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
HR - Croazia 2
JO - Giordania 2
MK - Macedonia 2
PA - Panama 2
QA - Qatar 2
SV - El Salvador 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GN - Guinea 1
Totale 23.477
Città #
Singapore 1.321
Woodbridge 1.294
Jacksonville 1.001
Chandler 962
Ashburn 951
Fairfield 893
Houston 786
Santa Clara 646
Beijing 626
Hong Kong 580
Ann Arbor 570
Wilmington 400
Dallas 309
Izmir 304
Seattle 293
Nanjing 286
Cambridge 263
Princeton 209
Munich 180
Los Angeles 179
Dearborn 168
Boardman 165
Warsaw 137
Ferrara 124
Ho Chi Minh City 117
New York 108
Shenyang 107
Nanchang 105
San Diego 99
São Paulo 83
Shanghai 78
Tianjin 75
Milan 72
Changsha 71
Hanoi 67
Turku 62
Addison 61
Hebei 59
Mexico City 58
Hefei 54
Bremen 49
Buffalo 48
Helsinki 47
Jiaxing 47
London 45
Mountain View 38
Tokyo 38
Brooklyn 36
Moscow 36
Jinan 34
Ningbo 34
Redwood City 33
Chicago 32
Montreal 30
Orange 30
Toronto 30
Kunming 29
San Francisco 29
Stockholm 29
Norwalk 27
San Mateo 27
Brno 26
Chennai 26
Frankfurt am Main 26
Phoenix 25
Bologna 24
Brussels 24
Poplar 24
Düsseldorf 23
Denver 22
Guangzhou 22
Zhengzhou 22
Boston 21
Atlanta 20
Curitiba 20
Rio de Janeiro 20
Washington 20
Auburn Hills 19
Orem 19
Johannesburg 18
Leawood 18
Haiphong 17
Manchester 17
Augusta 16
Falkenstein 16
Falls Church 15
Indiana 14
Mumbai 14
Patiala 13
Porto Alegre 13
Vienna 13
Jakarta 12
Philadelphia 12
Ankara 11
Belo Horizonte 11
Biên Hòa 11
Da Nang 11
Fuzhou 11
Rome 11
Amsterdam 10
Totale 15.358
Nome #
Thermodynamic characterization of substrate and inhibitor binding to Trypanosoma brucei 6-phosphogluconate dehydrogenase 264
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 230
6-Phosphogluconate dehydrogenase from Trypanosoma brucei - Kinetic analysis and inhibition by trypanocidal drugs 220
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 209
Differentiation between the structural and redox roles of TPNH in 6-phosphogluconate dehydrogenase 200
A rapid method for purification of myelin basic protein 195
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 193
Role of Methionine 13 in the catalytic mechanism of 6-phosphogluconate dehydrogenase from sheep liver 191
6-phosphogluconate dehydrogenase: structural symmetry and functional asymmetry 188
Inhibitors of Trypanosoma brucei 6-phosphogluconate dehydrogenase 187
A role for the pyridine nitrogen of reduced triphosphopyridine-nucleotide in the mechanism of action of isocitrate dehydrogenase 185
Antiprotozoal activity of 6-aminonicotinamide against Leishmania infantum promastigotes 185
HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies 183
A new powerful inhibitor specific for the TPN binding site of 6-phosphogluconate dehydrogenase 178
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 177
Activation of the sendai virus fusion protein by receptor binding 177
A role for the pyridine nitrogen of reduced triphosphopyridinenucleotide in an enzymatic catalysis 175
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 175
Identification of the chemical groups involved in the binding of periodate-oxidized NADP+ to 6-phosphogluconate dehydrogenase. 174
Mutual communication of envelope glycoproteins of paramixoviruses 173
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 171
Activation of the Sendai virus fusion protein by receptor binding 170
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 167
Isotope effect as a probe of the catalytic rilevance of coenzyme isomerization in the enzyme 6-phosphogluconate dehydrogenase from sheep liver 163
Affinity labelling of the NADP+-binding site of glucose 6-phosphate dehydrogenase from Candida utilis 159
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 159
Proper orientation of the nicotinamide ring of NADP is important for the precatalytic conformational change in the 6-phosphogluconate dehydrogenase reaction 158
6-Phosphogluconate dehydrogenase mechanism: Evidence for allosteric modulation by substrate 156
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 156
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 155
Le beta-esosaminidasi liquorali in sogetti affetti da sclerosi multipla e in controlli sani 154
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 151
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 150
Substrate binding to 6-phosphogluconate dehydrogenase 150
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 149
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 148
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 148
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 148
Surface mapping of Env protein from HIV by chemical modifications 147
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 147
Role of methionine-13 in the catalytic mechanism of 6-phosphogluconate dehydrogenase from sheep liver 147
6-phosphogluconate dehydrogenase: a target for drugs in African trypanosomiasis 146
X-ray escaping conformational changes affecting enzymatic function 145
Analisi della proteina basica della mielina nel liquor 145
Substrate-induced intramolecular proton transfer in 6-phosphogluconate dehydrogenase from Candida utilis 142
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 142
Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein 139
X-ray escaping conformational changes affecting enzymatic function 139
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 139
Thermodynamic characterization by ITC and DSC of the binding of 4-phospho-d-erythronate to the target enzyme T. brucei 6-phosphogluconate dehydrogenase 137
NADPH activates a decarboxylation reaction catalysed by lamb liver 6-phosphogluconate dehydrogenase 137
Evidence for dimer/tetramer equilibrium in Trypanosoma brucei 6-phosphogluconate dehydrogenase 137
Isothermal titration calorimetry tool to better characterize the mechanism of T. brucei 6-phosphogluconate dehydrogenase 136
Non-enzymic protein phosphorylation. Phosphorylation of 6-phosphogluconate dehydrogenase by acyl phosphates 136
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 136
The stabilization by a coenzyme analog of a conformational change induced by substrate in 6-phosphogluconate dehydrogenase 135
Is there an alternating site co-operativity between the two subunits of lamb liver 6-phosphogluconate dehydrogenase? 135
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 135
Alkylation of 6-phosphogluconate dehydrogenase from Candida utilis with coenzyme analogues 135
Mild proteolysis induces a ready-to-fuse state on Sendai virus envelope 134
A new hypothesis on the mechanism of action of lamb liver 6-phosphogluconate dehydrogenase 134
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 134
A Real-Time PCR to Detect Leishmania Infantum DNA in Immunocompetent Patients with Chronic Inflammatory Rheumatisms Living in Rural Areas of Northern Italy and Treated with Biologic Drugs. 134
Sugar derivatives as new 6-phosphogluconate dehydrogenase inhibitors selective for the parasite Trypanosoma Brucei 133
Dynamics of phosphorus in the Venice lagoon during a picocyanobacteria bloom 133
Bromopyruvate for the affinity labelling of a single cysteine residue near the carboxylate binding site of lamb liver 6-phosphogluconate dehydrogenase 133
"Do the two subunits of lamb liver 6-phosphogluconate dehydrogenase alternate their role during catalysis?" 133
A further non-redox role for NADPH in the mechanism of action of 6-pho-sphogluconate dehydrogenase from lamb liver 132
Evidence for multiple pairs of vicinal thiols in some proteins 131
Use of Trinitrobenzensulfonate for Affinity Labeling of Lysine Residues at Phosphate Binding Sites of Some Enzymes 131
A multiple role for the coenzyme in the mechanism of action of 6-phosphogluconate dehydrogenase 131
Alternating site catalytic cooperativity in some 6-phosphogluconate dehydrogenases 131
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 130
Anomeric specificity of the neuraminidase from sendai virus 130
A catalytic tyrosine at the active site of sendai virus neuraminidase 129
Biochemical study in adult population with stroke in Ferrara, Fabry disease 129
The mechanism of 6PGDH investigated by kinetics isotope effects 129
null 128
6-Phosphogluconate dehydrogenase: the mechanism of action investigated by a comparison of the enzyme from different species 128
Energy cost for the proper ionization of active site residues in 6-phosphogluconate dehydrogenase from T. brucei 127
Elevato riscontro di DNA circolante di Leishmania infantum in soggetti immunocompetenti affetti da malattie reumatologiche e trattati con farmaci biotecnologici. 127
Myelin basic protein inhibits the calcium response to phytohaemagglutinin in human lymphocytes 126
Evidences for the proximity of two sulfhydryl groups in the active site of 6-phosphogluconate dehydrogenase 126
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 125
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 125
Pharmacological potential of inhibitors of 6-phosphogluconate dehydrogenase from T.brucei: differentiation of substrate analogues from reaction-intermediate analogues by isothermal titration calorimetry 123
Half-site reactivity in 6-phosphogluconate dehydrogenase from human erythrocytes 123
Studies of Interaction between Sendai Virus Envelope Glycoproteins (HN ad F) by Syntetic peptides derived from the HR2 Region of the F Protein 122
6-fosfogluconato deidrogenasi da eritrociti umani: interazione con i coenzimi 122
Features of hypereutrophic Molino lagoon ecosystem dominated by sedentary polychaetes 122
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 122
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 122
Evidence for the proximity of a cysteinyl and a tyrosyl residue in the active sita of 6-phosphogluconate dehydrogenase 121
Domain structure of the hemagglutinin-neuraminidase from sendai virus 118
Preliminary cheracterization of recombinant hemagglutinin from Mumps virus 117
Biochemical characterization of the natural Cys386-FX variant: a new tool to investigate coagulation factor X functions? 116
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 115
Caratterizzazione di una proteina del LCS che interagisce con la proteina basica della mielina 115
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 113
Cysteine 365 may have a role in the catalytic mechanism of 6-Phosphogluconate Dehydrogenase from Sheep Liver 113
Totale 14.775
Categoria #
all - tutte 111.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 567
Totale 111.960


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.257 0 0 0 0 0 207 108 246 36 247 332 81
2021/20221.751 33 189 85 68 96 71 36 84 51 177 180 681
2022/20232.055 210 156 54 244 379 290 64 208 251 18 114 67
2023/2024843 93 123 48 30 81 120 16 60 15 15 21 221
2024/20253.743 101 80 335 147 496 266 146 202 542 471 531 426
2025/20265.629 1.047 513 1.005 1.401 1.538 125 0 0 0 0 0 0
Totale 23.684